ASCERTAIN - IMPACT OF INTRAVENOUS ABATACEPT ON SYNOVITIS, OSTEITIS AND STRUCTURAL DAMAGE IN PATIENTS WITH RHEUMATOID ARTHRITIS AND AN INADEQUATE RESPONSE TO METHOTREXATE: A RANDOMISED CONTROLLED TRIAL Trademark
Trademark Overview
On Thursday, January 26, 2012, a trademark application was filed for ASCERTAIN - IMPACT OF INTRAVENOUS ABATACEPT ON SYNOVITIS, OSTEITIS AND STRUCTURAL DAMAGE IN PATIENTS WITH RHEUMATOID ARTHRITIS AND AN INADEQUATE RESPONSE TO METHOTREXATE: A RANDOMISED CONTROLLED TRIAL with the United States Patent and Trademark Office. The USPTO has given the ASCERTAIN - IMPACT OF INTRAVENOUS ABATACEPT ON SYNOVITIS, OSTEITIS AND STRUCTURAL DAMAGE IN PATIENTS WITH RHEUMATOID ARTHRITIS AND AN INADEQUATE RESPONSE TO METHOTREXATE: A RANDOMISED CONTROLLED TRIAL trademark a serial number of 85525635. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Monday, July 1, 2013. This trademark is owned by Bristol-Myers Squibb Company. The ASCERTAIN - IMPACT OF INTRAVENOUS ABATACEPT ON SYNOVITIS, OSTEITIS AND STRUCTURAL DAMAGE IN PATIENTS WITH RHEUMATOID ARTHRITIS AND AN INADEQUATE RESPONSE TO METHOTREXATE: A RANDOMISED CONTROLLED TRIAL trademark is filed in the Computer & Software Services & Scientific Services category with the following description:
Medical and scientific research, namely, conducting clinical trials and clinical studies relating to pharmaceutical preparations for human use for pharmaceutical research and development
General Information
| Serial Number | 85525635 |
| Word Mark | ASCERTAIN - IMPACT OF INTRAVENOUS ABATACEPT ON SYNOVITIS, OSTEITIS AND STRUCTURAL DAMAGE IN PATIENTS WITH RHEUMATOID ARTHRITIS AND AN INADEQUATE RESPONSE TO METHOTREXATE: A RANDOMISED CONTROLLED TRIAL |
| Filing Date | Thursday, January 26, 2012 |
| Status | 602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE |
| Status Date | Monday, July 1, 2013 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | NOT AVAILABLE |
Trademark Statements
| Disclaimer with Predetermined Text | "IMPACT OF INTRAVENOUS ABATACEPT ON SYNOVITIS, OSTEITIS AND STRUCTURAL DAMAGE IN PATIENTS WITH RHEUMATOID ARTHRITIS AND AN INADEQUATE RESPONSE TO METHOTREXATE: A RANDOMISED CONTROLLED TRIAL" |
| Goods and Services | Medical and scientific research, namely, conducting clinical trials and clinical studies relating to pharmaceutical preparations for human use for pharmaceutical research and development |
Classification Information
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, January 30, 2012 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
Trademark Owner History
| Party Name | Bristol-Myers Squibb Company |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | New York, NY 10154 |
Trademark Events
| Event Date | Event Description |
| Monday, July 1, 2013 | ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND |
| Monday, July 1, 2013 | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE |
| Tuesday, March 12, 2013 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Thursday, November 15, 2012 | NOTIFICATION OF FINAL REFUSAL EMAILED |
| Thursday, November 15, 2012 | FINAL REFUSAL E-MAILED |
| Thursday, November 15, 2012 | FINAL REFUSAL WRITTEN |
| Wednesday, November 14, 2012 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Tuesday, November 13, 2012 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Tuesday, November 13, 2012 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Tuesday, July 10, 2012 | ASSIGNED TO EXAMINER |
| Friday, May 18, 2012 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Friday, May 18, 2012 | NON-FINAL ACTION E-MAILED |
| Friday, May 18, 2012 | NON-FINAL ACTION WRITTEN |
| Saturday, May 5, 2012 | ASSIGNED TO EXAMINER |
| Monday, January 30, 2012 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM |
| Monday, January 30, 2012 | NEW APPLICATION ENTERED IN TRAM |
